- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Stocks to buy in 2025 for long term: Sun Tv, Glenmark Pharma among 5 stocks that could give 17-33% return | 4 | Times of India | ||
| Di | Glenmark Pharma gets EC nod for acne drug Winlevi in 15 European countries | 3 | capitalmarket.com | ||
| Mo | Glenmark Pharma gains after Q2 PAT climbs 72% YoY to Rs 610 cr | 2 | capitalmarket.com | ||
| 15.11. | Glenmark Pharma Q2 PAT climbs 72% YoY to Rs 610 cr | 4 | capitalmarket.com | ||
| 15.11. | Glenmark Pharmaceuticals Reports 72.2% Jump In Profit After Tax At Rs 610.43 Crore Due To Licensing Deal With AbbVie | 14 | The Free Press Journal | ||
| GLENMARK PHARMACEUTICALS Aktie jetzt für 0€ handeln | |||||
| 14.11. | Glenmark Pharmaceuticals Ltd spurts 2.55%, gains for third straight session | 3 | capitalmarket.com | ||
| 04.11. | Glenmark Pharma's US subsidiary to launch 8.4% sodium bicarbonate injection in US market | 2 | capitalmarket.com | ||
| 03.11. | Glenmark Pharmaceuticals Ltd spurts 0.02%, rises for fifth straight session | 4 | capitalmarket.com | ||
| 30.10. | Glenmark Pharmaceuticals Ltd up for third consecutive session | 3 | capitalmarket.com | ||
| 30.10. | Import von Glenmark: Engpass: Salbutamol aus Brasilien | 3 | APOTHEKE ADHOC | ||
| 23.10. | Glenmark Pharma set to launch Ropivacaine Hydrochloride Injection in US | 3 | capitalmarket.com | ||
| 28.09. | Glenmark, Granules, Zydus and others recall medicines in US over quality issues: USFDA | 2 | ZEE Business | ||
| 26.09. | Fierce Pharma Asia-Celltrion's Lilly plant buy; Rexulti's PTSD snub; Glenmark, Hengrui's ADC deal | 6 | FiercePharma | ||
| 25.09. | China's Hengrui Rises After Granting India's Glenmark Cancer Drug Rights in Up to USD1.1 Billion Deal | 2 | Yicai Global | ||
| 25.09. | Stock Alert: Glenmark Pharmaceuticals, Lupin, NTPC, Pipavav Port, Newgen | 2 | capitalmarket.com | ||
| 24.09. | In potential $1.1B deal, Glenmark grabs certain rights to Hengrui's ADC rival to Enhertu | 3 | FiercePharma | ||
| 15.09. | Dividendenbekanntmachungen (15.09.2025) | 13.695 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) A&W FOOD SERVICES OF CANADA INC CA0002251027 0,48 CAD 0,2954 EUR ALLEGION PLC IE00BFRT3W74 0,51 USD 0,4345 EUR ALTRIA GROUP INC US02209S1033 1... ► Artikel lesen | |
| 08.09. | Glenmark Expands Phase 3 Study of Envafolimab to Multiple Regions | 2 | Mexico Business News | ||
| 05.09. | Glenmark Pharmaceuticals: Glenmark Initiates a Multi-Country Phase 3 Clinical Trial for Envafolimab in Resectable Stage III Non-Small Cell Lung Cancer | 329 | PR Newswire |
DCGI grants No Objection Certificate to commence enrollment in India
Clinical Trial Applications underway in Russia, Brazil, and Mexico
MUMBAI, India, Sept. 5, 2025 /PRNewswire/... ► Artikel lesen | |
| 05.09. | Glenmark Pharmaceuticals: Glenmark Initiates a Multi-Country Phase 3 Clinical Trial for Envafolimab in Resectable Stage III Non-Small Cell Lung Cancer | 388 | PR Newswire | DCGI grants No Objection Certificate to commence enrollment in India
Clinical Trial Applications underway in Russia, Brazil, and Mexico
MUMBAI, India, Sept. 5, 2025 /PRNewswire/... ► Artikel lesen |
1 2 3 4 Weiter >>
75 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SINOPHARM | 2,212 | -1,86 % | Sinopharm Group-Aktie heute gut behauptet: Aktienwert steigt (2,08 €) | Der Anteilsschein der Sinopharm Group notiert heute ein wenig fester. Zuletzt zahlten Investoren für das Wertpapier 2,08 Euro. Jahreschart der Sinopharm Group Ltd-Aktie, Stand 11.09.2025 Freuen können... ► Artikel lesen | |
| CSPC PHARMA | 0,816 | -1,69 % | CSPC PHARMA (01093): VOLUNTARY ANNOUNCEMENT - A SELECTIVE 5-HT2A RECEPTOR AGONIST (SYH2056 TABLETS) OBTAINS CLINICAL TRIAL APPROVAL IN CHINA | ||
| WUXI BIOLOGICS | 3,413 | +1,40 % | WuXi Biologics-Aktie leicht im Plus (4,441 €) | Das Wertpapier von WuXi Biologics notiert heute fester. Das Papier kostete zuletzt 4,44 Euro. Ein Preisanstieg in Höhe von 17 Cent erfreut derzeit die Aktionäre von WuXi Biologics. Zur Stunde kostet... ► Artikel lesen | |
| SHANGHAI FOSUN PHARMACEUTICAL | 2,402 | -1,07 % | FOSUN PHARMA (02196): OVERSEAS REGULATORY ANNOUNCEMENT - ANNOUNCEMENT IN RELATION TO THE ACCEPTANCE OF A SUBSIDIARY'S DRUG REGISTRATION APPLICATION | ||
| GEDEON RICHTER | 24,720 | 0,00 % | Gedeon Richter Plc.: Long-term Commitment to Treating Endometriosis and Improving Women's Quality of Life - Gedeon Richter at the World Congress on Endometriosis | SYDNEY, May 28, 2025 /PRNewswire/ --
Gedeon Richter had a strong presence at the World Congress of Endometriosis held this year in Sydney, Australia between 21-24 May 2025. As a Platinum... ► Artikel lesen | |
| DR REDDYS | 12,300 | +1,65 % | Dr Reddys Laboratories Ltd up for fifth session | ||
| ASPEN PHARMACARE | 4,640 | +1,31 % | ASPEN PHARMACARE HOLDINGS LIMITED - Notification in terms of Section 122 (3) of the Companies Act and Section 3.83(b) of the JSE Listings Requirements | ||
| LUYE PHARMA | 0,324 | -3,57 % | LUYE PHARMA (02186): DISCLOSEABLE TRANSACTION ISSUE OF EXCHANGEABLE PREFERENCE SHARES BY A WHOLLY-OWNED SUBSIDIARY OF THE COMPANY | ||
| SHANGHAI PHARMACEUTICALS | 1,360 | +3,03 % | SH PHARMA (02607): INTERIM DIVIDEND FOR THE SIX MONTHS ENDED 30 JUNE 2025 (UPDATED) | ||
| SIHUAN PHARMACEUTICAL HOLDINGS GROUP | 0,142 | -5,33 % | SIHUAN PHARM (00460): VOLUNTARY ANNOUNCEMENT - PROPOSED IMPLEMENTATION OF THE H SHARE FULL CIRCULATION BY XUANZHU BIOPHARMA | ||
| CHINA RESOURCES PHARMACEUTICAL | 0,515 | 0,00 % | CHINARES PHARMA (03320): INSIDE INFORMATION COMPLETION OF THE PUBLIC ISSUANCE OF THE SECOND TRANCHE OF 2025 CORPORATE BONDS IN THE PRC | ||
| HANSOH PHARMACEUTICAL | 4,240 | -0,93 % | Dividendenbekanntmachungen (22.09.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AECON GROUP INC CA00762V1094 0,19 CAD 0,1173 EUR APT SATELLITE HOLDINGS LTD BMG0438M1064 0,025 HKD 0,0027 EUR ARROWMARK FINANCIAL... ► Artikel lesen | |
| CHINA SHINEWAY PHARMACEUTICAL GROUP | 0,930 | -1,59 % | Dividendenbekanntmachungen (09.09.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ALUMINUM CORPORATION OF CHINA LTD CNE1000001T8 0,1348 HKD 0,0147 EUR AMEREN CORPORATION US0236081024 0,71 USD 0,6037 EUR ANHUI... ► Artikel lesen | |
| KALBE FARMA | 0,060 | +11,11 % | Kalbe Farma profit rises 10.63%, shares react positively: The shares of this Indeks52 constituent climb 3.25% ... | ||
| YICHANG HEC CHANGJIANG PHARMACEUTICAL | - | - | HEC CJ PHARM (01558): JOINT ANNOUNCEMENT UPDATE REGARDING CONDITIONAL PRIVATISATION OF YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD. BY SUNSHINE LAKE ... |
Das Unternehmen GLENMARK PHARMACEUTICALS LTD kann der Branche Pharma zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu GLENMARK PHARMACEUTICALS LTD finden Sie auf Wallstreet Online.